Inside One Company’s Quest to Develop a COVID-19 Antibody Treatment: A Q&A with Regeneron’s George Yancopoulos
While teams race to develop a vaccine, Regeneron’s treatment would use antibodies to give patients short-term immunity.
While teams race to develop a vaccine, Regeneron’s treatment would use antibodies to give patients short-term immunity.